We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
+11.77%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$247M
AUM Growth
+$30.1M
(+14%)
Cap. Flow
+$15.2M
Cap. Flow
% of AUM
6.13%
Top 10 Holdings %
Top 10 Hldgs %
27.01%
Holding
126
New
13
Increased
59
Reduced
18
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lyft
LYFT
|
+$3.28M |
| 2 |
Grid Dynamics Holdings
GDYN
|
+$2.88M |
| 3 |
AIOT
PowerFleet Inc
AIOT
|
+$2.81M |
| 4 |
DHT Holdings
DHT
|
+$2.29M |
| 5 |
Meritage Homes
MTH
|
+$1.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$9.27M |
| 2 |
WNS
WNS Holdings
WNS
|
+$7.14M |
| 3 |
Tandem Diabetes Care
TNDM
|
+$3.52M |
| 4 |
GTLS
Chart Industries
GTLS
|
+$2.95M |
| 5 |
Lantheus
LNTH
|
+$2.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Industrials | 18.49% |
| 3 | Healthcare | 10.66% |
| 4 | Financials | 10.15% |
| 5 | Consumer Discretionary | 9.65% |
Similar funds
KA
LCGC
DEA
EAN
PIP
VIG
SC
L
1492 Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, 1492 Capital Management held 126 positions worth $247M, up 14% from $217M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
1492 Capital Management deployed $15.2M of net new capital in Q3 2025, opening 13 new positions and adding to 59 existing holdings. Its largest new stake was AIRO Group Holdings: 72,173 shares worth $1.39M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Lantheus, an estimated $2.16M trimmed.
- 1492 Capital Management's largest Q3 2025 buy was AIRO Group Holdings: 72,173 shares worth $1.39M.
- 1492 Capital Management added most to Lyft in Q3 2025, an estimated $3.28M increase.
- 1492 Capital Management's biggest Q3 2025 reduction was Lantheus, cutting an estimated $2.16M.
- 1492 Capital Management fully exited Verona Pharma in Q3 2025, selling an estimated $9.27M.
- 1492 Capital Management's ten largest holdings make up 27% of its $247M portfolio in Q3 2025.
- 1492 Capital Management opened 13 new positions and closed 13 in Q3 2025.
- 1492 Capital Management's portfolio value rose 14% quarter-over-quarter to $247M.
Based on 1492 Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.